PAMIDRONATE TO REDUCE BONE PAIN IN NORMOCALCAEMIC PATIENT WITH DISSEMINATED PROSTATIC CARCINOMA
- 6 May 1989
- journal article
- Published by Elsevier in The Lancet
- Vol. 333 (8645) , 1021-1022
- https://doi.org/10.1016/s0140-6736(89)92665-2
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancyBMJ, 1988
- 3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancerBritish Journal of Cancer, 1987
- Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer.BMJ, 1987
- COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIAThe Lancet, 1983